RNAGADE
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Oct 2025)
What this means for you
This application is over — abandoned 15 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90545048
- Mark type
- Stylized text
- Filed
- 24 Feb 2021
- Published for opposition
- 01 Mar 2022
- Abandoned
- 15 Oct 2025
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 001 — Chemicals: Biochemical catalysts; Biochemical preparations for scientific purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations used in science; Nucleic acid for laboratory use; Protein in raw material form for scientific and medical research; Reagents for research purposes; Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; Antioxidants for use in the manufacture of pharmaceuticals; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biometallic compounds for use in the manufacture of pharmaceutical preparations; Catalysts for chemical and biochemical processes; Cells for scientific, laboratory or medical research; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the biochemical and chemical industry; Chemicals for use in the purification of proteins for in vitro use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Enzymes for use in protein hydrolysis; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Plant extracts for use in the manufacture of pharmaceuticals; Protein arrays and nucleotide arrays for scientific and medical research; Reagents for scientific or medical research use
Owner
- Renagade Therapeutics LLC, Watertown, MA, US
- Renagade Therapeutics LLC, Cambridge, MA, US
Prosecution history
- 15 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2024 — SOU EXTENSION 5 GRANTED
- 24 Oct 2024 — SOU EXTENSION 5 FILED
- 24 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2024 — SOU EXTENSION 4 GRANTED
- 04 Mar 2024 — SOU EXTENSION 4 FILED
- 04 Mar 2024 — SOU TEAS EXTENSION RECEIVED